ライフサイエンスコーパス: avid

1 PET/CT, as the metastases were not (18)F-FDG-avid.

2 ging, as lymphomas are 18-fluorodeoxyglucose avid.

3 cellular carcinoma (HCC) that is not 18F-FDG-avid.

4 ly large lesions (19.5%) remained [(18)F]FDG avid.

5 n the ferrous deoxygenated state, and oxygen-avid.

6 escribe a new global alignment method called AVID.

7 47S isoprotein is predicted to be less lipid avid.

8 nchyma, or chest wall and were all (18)F-FDG avid.

9 anced breast cancers were (18)F-fluciclovine-avid.

10 9 participants from four cohorts in the USA (Avid 05e, n = 157; Expedition-3, n = 82; ADNI, n = 123)

11 etecting coronary plaque has been limited by avid (18)F-FDG uptake by the myocardium.

12 nd neck and esophageal carcinoma demonstrate avid (18)F-FDG uptake.

13 asmic enzymes in gram-negative bacteria with avid ability for beta-lactam turnover.

14 ifying enzymes and genotypes conferring less-avid AChEi detoxification.

15 ine regulatory mechanisms restraining energy-avid adaptive immunity in times of starvation and exerti

16 CT for the detection of unexpected (18)F-FDG-avid additional primary malignant tumors in patients bei

17 Seventy-one patients with (18)F-FDG-avid adenocarcinoma of the pancreas before treatment wer

18 -tg mice was virtually absent in contrast to avid adhesion in WT mice.

19 he mixed-pattern lesions remained [(18)F]FDG avid after treatment.

20 rates SLAM with repeat masking tools and the AVID alignment program to allow for rapid alignment and

21 unctional parameters-number of (11)C-acetate-avid and (18)F-FDG-avid focal bone lesions and (11)C-ace

22 ntiated thyroid cancers are typically iodine-avid and can be effectively treated with radioiodine.

23 that oxidation of 13C-octanoate in brain is avid and contributes approximately 20% to total brain ox

24 G negative, but 12 (48%) remained [(18)F]FDG avid and increased in size on CT.

25 cers, some gastric cancers are not (18)F-FDG-avid and its clinical value is still debatable.

26 assays, but responder animals showed a more avid and persistent IFN-gamma response.

27 ximal regions usually correspond to sites of avid and persistent sister chromatid cohesion mediated b

28 eighted signal intensity in five women, more avid and rapid contrast enhancement in five, and early c

29 l) to maximally increase brain uptake of the avid and selective P-gp substrate (11)C-N-desmethyl-lope

30 m phase separation with RNA (coacervates) to avid and specific double-stranded DNA binding.

31 istant cells that are unresponsive to highly avid and specific melanoma-reactive CTLs, despite mainta

32 ll cell lung cancer is fluorodeoxy-D-glucose avid and that positron emission tomography has potential

33 ould further be improved by using more tumor-avid and/or target-specific photosensitizers.

34 ha- and beta-chains of the TCR from a highly avid anti-gp100 CTL clone were isolated and used to cons

35 MS2-3C8 binds MBP-DR4 as tightly as the most avid anti-microbial TCRs.

36 ytes was confirmed in comparison with highly avid antimelanoma lymphocytes by the high levels of cyto

37 motherapy followed by the transfer of highly avid antitumor lymphocytes can mediate significant tumor

38 Early identification of infants with avid appetites may make it possible to implement strateg

39 r the three GST isozymes, results suggesting avid associations between GST and 15-d-PGJ(2) or 15-d-PG

40 ation reverses strong learned revulsion into avid attraction.

41 xillary nodal metastases, (18)F-fluciclovine-avid axillary nodes were seen in 20.

42 The most avid binder, a pentamer, binds the rCUG repeat hairpin w

43 Both NOXA and Bim are avid binders of Mcl-1, but a functional linkage between

44 p80 UIMs positions the domains for efficient avid binding across a single K63 linkage, thus defining

45 e not effective in clinical trials, but more avid binding agents may be.

46 of delivery vectors by humoral immunity, and avid binding between enzyme and its DNA target will prom

47 oncomitant blockage of multiple epitopes and avid binding by fusing multiple (different) monovalent N

48 the O-antigen-deficient mutant in regard to avid binding by murine complement C3 or resistance to se

49 ealed structural insights into the nature of avid binding by the BhCBM6/56 pair and how the orientati

50 an interactions are typically very weak, and avid binding is achieved when proteins express multiple

51 o high streptavidin density, suggesting that avid binding may require engagement of more than four tr

52 st clearance and low hepatic background, the avid binding of 99mTc-duramycin to the infarcted myocard

53 The avid binding of AID to ssDNA could result from its large

54 We report avid binding of LPA to the receptor for advanced glycati

55 l activity of CD4-BFFI is most likely due to avid binding of the bivalent FI peptides as well as the

56 The avid binding of tissue inhibitors of metalloproteinases

57 The avid binding of USF1/2 heterodimers to these E-boxes occ

58 mAbs, the EPTP-directed mAbs showed far less avid binding to brain tissue and were consistently detec

59 t this enhancement is a direct result of its avid binding to the coactivator CREB binding protein (CB

60 y connected VHS and UIM motifs of ESCRT-0 in avid binding to the polyubiquitin chain.

61 Among these, avid binding was detected to a single defined glycan, Ne

62 binding to sialosides, the D151G NA exhibits avid binding with broad specificity toward alpha2-3 sial

63 uptake (TLF10) and total volume of fluoride avid bone metastases (FTV10).

64 y mass and lymph nodes and shows several PET-avid bone metastases.

65 ors and those within the hypermetabolic, PET-avid brain were falsely negative.

66 IM to Lys(63)-linked diubiquitin is not only avid, but also cooperative.

67 of focal lesions (FLs), especially when FDG-avid by PET-computed tomography, was positively linked t

68 eractions of C17.2 NSCs with host axons, the avid C17.2 cell-host axon contacts, and the ensheathing

69 e arrangement of capsid subunits and enables avid capsid binding.

70 CVN potently blocks HIV entry through highly avid carbohydrate-mediated interactions with the HIV-env

71 m poorly, but the GES-5 beta-lactamase is an avid catalyst for turnover of this antibiotic.

72 )/CD45(+) macrophages as the most [(18)F]FDG-avid cell type present, yet they represented <5% of the

73 ls is due to a greater fraction of (18)F-FLT-avid cells rather than a change in (18)F-FLT uptake by i

74 At 20% serum, a subpopulation of (18)F-FLT-avid cells, representing 61% of the total population, em

75 lculated for the primary tumor and (18)F-FLT-avid cervical lymph nodes for all scans.

76 DIALIGN for local alignment and compared to AVID, ClustalW, DIALIGN and LAGAN for global alignment.

77 s over 70% identity over 100 bp) compared to AVID, ClustalW, DIALIGN and LAGAN.

78 BRAF mutation was associated with (18)F-FDG-avid CNS disease (P = 0.0357), higher SUVmax (P = 0.0044

79 between fluorine 18 fluorodeoxyglucose (FDG)-avid colonic lesions and immunohistochemical assay findi

80 amino acids, were found to produce the most avid competitors.

81 to DNA binding, as the clamp loader forms an avid complex with beta at a 5' site.

82 demonstrate that several types of cancer are avid consumers of acetate, which facilitates macromolecu

83 As(III) species, by avid coordination to the cysteine residues of unfolded r

84 While the avid dieter obsesses about reduction of different body p

85 with thyroid cancer and in patients with RAI-avid diffuse bilateral pulmonary metastases, even when r

86 female sex, subtotal thyroidectomy, and RAI-avid diffuse bilateral pulmonary metastases.

87 In this selected population, all had FDG-avid disease at baseline; by 5-PS, 55 (35%) remained pos

88 er better delineated the extent of (18)F-FDG-avid disease.

89 sk of PET/CT revealing unsuspected (18)F-FDG-avid distant metastases in stage III IDC patients was 2.

90 There were no patients with (18)F-FDG-avid distant metastases without (18)F-FES-avid distant m

91 DG-avid distant metastases without (18)F-FES-avid distant metastases, although in one patient liver m

92 nagement of thyroid cancer patients with RAI-avid distant metastases.

93 nagement of thyroid cancer patients with RAI-avid distant metastases.

94 PET studies showed rapid blood clearance and avid extraction of (18)F-FTO and of (18)F-FTP into the h

95 ulocytosis that was partially compensated by avid extramedullary erythropoiesis at all erythroid stag

96 The presence of more than 3 FDG-avid FLs, related to fundamental features of myeloma bio

97 s-number of (11)C-acetate-avid and (18)F-FDG-avid focal bone lesions and (11)C-acetate general marrow

98 Bilateral hilar (18)F-FDG-avid foci are often noted on PET studies of patients wit

99 lues (SUV max), purity (absence of (18)F-FDG-avid foci in nonhilar mediastinal nodes), symmetry (diff

100 (89)Zr-pertuzumab-avid foci that were suspicious for HER2-positive metasta

101 ith the finding of bilateral hilar (18)F-FDG-avid foci underwent a staging-only PET study; 52 scans f

102 Metastatic PSMA-avid foci were also visualized with (68)Ga-THP-PSMA PET.

103 Metastases avid for (89)Zr-trastuzumab by PET/CT were biopsied and

104 ed that (R)- and (S)-enantiomers are equally avid for GR by occupying discrete binding modes.

105 The binding of Nef was similarly avid for native HLA-I and recombinant HLA-I A2 at the PM

106 , many classes of brain tumors are generally avid for transferrin.

107 This avid formation of promoter complexes requires both linka

108 atment-naive patient the emergence of highly avid, gamma interferon-secreting, CD8(+) CTL recognizing

109 F-FDG is a well-established method using the avid glucose uptake of tumor cells.

110 Transferred PBMC contained highly avid, gp100:209-217 peptide-reactive CD8(+) T cells.

111 To facilitate their avid growth and proliferation, cancer cells not only alt

112 ovalent bond formation was not necessary for avid GST-nitroalkene interactions.

113 tures of the active site in the extremely O2-avid hemoglobin from the trematode Paramphistomum epicli

114 t underwent biopsy and RF ablation of an FDG-avid hepatic focus.

115 ells blockade of calcium currents results in avid high-frequency bursting, consistent with the notion

116 ET-CT will be used to assess response in FDG-avid histologies using the 5-point scale.

117 Micropeptides formed avid homo-oligomers with high-order stoichiometry (n > 2

118 because degenerative changes are not choline-avid; however, the agent may accumulate in recent trauma

119 99mTc-Glucarate is an infarct-avid imaging agent with the potential for very early det

120 c-Glucarate ((99m)Tc-GLA) is a novel infarct-avid imaging agent.

121 follow-up had fluorine 18 fluorodeoxyglucose-avid IMLN, with a median standardized uptake value of 2.

122 Only one of the 12 of the fluorodeoxyglucose-avid IMLNs was malignant, with a PPV of 0.083 (95% CI: 0

123 r, 12 (86%; 95% CI, 67%-100%) were (18)F-FDG-avid, including all those 10 mm or greater (mean standar

124 arbocation intermediate, suggesting that the avid inhibition by R- and S-azabisabolenes arises more f

125 ull-length ARRDC3 and Nedd4 is driven by the avid interaction of both PPXY motifs with either the WW2

126 with binding kinetics that suggest a highly avid interaction toward virion-associated envelope.

127 nd conformational variability may facilitate avid interactions with diverse substrates.

128 There is avid interest in noninvasive, inexpensive markers that h

129 All patients exhibited (123)I-MIBG-avid, International Neuroblastoma Staging System stage 4

130 e shown to be improved luminescent tags with avid lanthanide binding and up to 3-fold greater lumines

131 zed to lean body mass, of the most (18)F-FDG-avid lesion (PERCIST 1) and by the change in the sum of

132 The most (18)F-FDG-avid lesion according to PERCIST and imPERCIST accuratel

133 ing the SUL(peak) of only the most (18)F-FDG-avid lesion and analyzing up to the 5 most (18)F-FDG-avi

134 (18)F-FLT-avid lesions ( approximately 2/patient) were segmented o

135 18% (95% CI: 5%, 64%) for patients with FDG-avid lesions (P < .0001).

136 35% (95% CI: 20%, 61%) for patients with FDG-avid lesions (P = .014).

137 improved the overall detection rate of PSMA-avid lesions (p = 0.039).

138 f scans, there were a total of 254 (18)F-FES-avid lesions (SUV(max), 2.6-17.9) and 111 (18)F-FDG-avid

139 sions (SUV(max), 2.6-17.9) and 111 (18)F-FDG-avid lesions (SUV(max), 3.3-9.9) suggestive of malignanc

140 ithout implants but with confirmed (18)F-FDG-avid lesions adjacent to common implant locations.

141 y counted the number of suggestive (18)F-FDG-avid lesions and provided the TNM staging for the 5 pati

142 th aggressive lymphomas, the presence of FDG-avid lesions at PET/CT performed before allogeneic and a

143 portion of SPECT/CT demonstrated non-iodine-avid lesions in 32 of 148 patients.

144 nificance of [(18)F]fluorodeoxyglucose (FDG)-avid lesions in patients with lymphoma treated with stem

145 Results: PSMA-avid lesions in the prostate were identified in all 16 p

146 ficant effect on small, moderately (18)F-FDG-avid lesions near the implant site that possibly may go

147 (18)F-FDG-avid lesions not only were found in impinged spinal nerv

148 I], 2.3-28.3; P = .0008), fluorodeoxyglucose-avid lesions on baseline positron emission tomography (H

149 scans, there were no new positive (18)F-FDG-avid lesions outside the R-FOV, when compared with their

150 splantation patients rarely demonstrated FDG-avid lesions suggestive of disease without malignant pat

151 PET/CT examinations were evaluated for FDG-avid lesions suggestive of disease.

152 -cell transplantation recipients, 50 had FDG-avid lesions suggestive of lymphoma, defined as FDG-avid

153 ILC patients were upstaged by non-(18)F-FDG-avid lesions visible only on the CT images.

154 e 5 of 7 patients, the SUV(max) of (18)F-FES-avid lesions was greater than the SUV(max) of (18)F-FDG-

155 zed uptake value (SUV) of the most (18)F-FDG-avid lesions was recorded.

156 Results: Eighty-seven (18)F-FDHT-avid lesions were evaluated.

157 Results: A total of 35 (18)F-NaF-avid lesions were identified in 28 patients.

158 Two hundred twenty-seven tracer-avid lesions were identified in 50 patients.

159 ogeneic SCT, 23 of 73 patients (32%) had FDG-avid lesions, and before autologous SCT, 11 of 102 patie

160 % (95% CI: 64%, 82%) in patients without FDG-avid lesions, but only 18% (95% CI: 5%, 64%) for patient

161 rval [CI]: 56%, 82%) in patients without FDG-avid lesions, but only 35% (95% CI: 20%, 61%) for patien

162 yzed to determine the total number of tracer-avid lesions, organ systems of involvement, and SUV(max)

163 On larger, highly (18)F-FDG-avid lesions, the metallic implants had only a limited e

164 logous SCT, 11 of 102 patients (11%) had FDG-avid lesions.

165 d standardized uptake value (SUV) in focally avid lesions.

166 des was comparable with patients without FDG-avid lesions.

167 ion and analyzing up to the 5 most (18)F-FDG-avid lesions.

168 s was greater than the SUV(max) of (18)F-FDG-avid lesions.

169 60 minutes can improve the detection of PSMA-avid lesions.

170 There was avid localization of ICG to the focal lesions at all tim

171 tation of patients with lymphoma, benign FDG-avid </= 1.5 cm lymph nodes can mimic malignancy.

172 Disease-free survival of patients with FDG-avid </= 1.5 cm lymph nodes was comparable with patients

173 was matched by significant decreases in FDG-avid lung and mediastinal node disease.

174 he dosimetry of thyroid cancer patients with avid lung metastases that exhibit prolonged retention in

175 vent lung toxicity in the presence of iodine-avid lung metastases.

176 In 21 of 22 patients with FDG-avid lymph nodes </= 1.5 cm, biopsy attempts were benign

177 c stem-cell transplantation demonstrated FDG-avid lymph nodes up to 1.5 cm in short axis on PET/CT, w

178 In 1 of 6 patients, (18)F-FDG-avid lymph nodes were not identified as pathologic on CT

179 of the most and least 18F-fluorodeoxyglucose-avid lymphoma sites) was 8.0 (range, 1.1-23.9) vs 7.1 (r

180 ponse assessment for [18F]fluorodeoxyglucose-avid lymphomas in clinical practice and late-phase trial

181 y incorporated into standard staging for FDG-avid lymphomas.

182 a-labeled prostate-specific membrane antigen-avid malignancies were rare (0.7%) in PC patients; atypi

183 se and development of new sites of (18)F-FDG-avid malignancy.

184 helpful when fluorine 18 fluorodeoxyglucose-avid masses that are not seen sufficiently with nonenhan

185 de ascr#10, causes reduced exploration, more avid mating, and improved reproductive performance (see

186 Methods: 50 patients with PSMA-avid mCRPC who had progressed after standard therapies r

187 EM PSF was seen in cases of mildly (18)F-FDG-avid mediastinal nodes in lung cancer and small liver me

188 ry tumour site plus meta-iodobenzylguanidine avid metastases present before myeloablative therapy, fo

189 A total of 67 choline-avid metastases were identified: 44 bone lesions and 23

190 One patient had (18)F-FES-avid metastases with no corresponding (18)F-FDG-avid met

191 For (18)F-FDG-avid metastases, the relative risk of PET/CT revealing u

192 d metastases with no corresponding (18)F-FDG-avid metastases.

193 All 20 demonstrated (18)F-FDG-avid metastases.

194 Methods: Fifty patients with PSMA-avid metastatic castration-resistant prostate cancer who

195 -fluorodeoxyglucose at detecting non-glucose-avid metastatic lesions.

196 trospectively analyzed 352 patients with RAI-avid metastatic well-differentiated TC treated with (131

197 trospectively analyzed 352 patients with RAI-avid metastatic well-differentiated TC treated with (131

198 we have identified a peptide with projected avid MHC-binding activity that elicited immunoreactivity

199 ly used measures of evolutionary constraint (AVID, MLAGAN, SLAGAN, phastCons, WebMCS) demonstrate tha

200 iodobenzylguanidine ((124)I-MIBG) in an MIBG-avid model was performed.

201 merization with FHR2 and FHR5 generates more avid molecules that very effectively compete with FH bin

202 alpha- and beta-chain of a TCR from a highly avid murine CTL clone that recognized the human p53(264-

203 However, avid myocardial glucose uptake may preclude its use for

204 Quantification of FDG-avid myocardium using cardiac metabolic volume is propos

205 ts with the nephrotic syndrome is limited by avid Na(+) reabsorption by the terminal nephron.

206 For this purpose, we developed a bone marrow-avid nanobiologic platform designed specifically to indu

207 gent FTP11-CyAm7 and dextranated, macrophage-avid nanoparticles CLIO-VT680.

208 d tomography (PET-CT) imaging of macrophages-avid nanoparticles detects rejection of heart allografts

209 e have synthesized a library of GRP receptor-avid nanoplatforms by conjugating gold nanoparticles (Au

210 % higher than that of (124)I-MIBG in an MIBG-avid neuroblastoma model.

211 ated with pTR, in 82 patients with (18)F-FDG-avid nodes before NAC we observed mNR in 10 (12.2%) not

212 d higher sensitivity than MR imaging for FDG-avid nodules (95.6% vs 80.0%, P = .008).

213 gly recommend investigation of all (18)F-FDG-avid nodules 1 cm or larger with ultrasound and fine-nee

214 ave high sensitivity in the detection of FDG-avid nodules and nodules 0.5 cm in diameter or larger, w

215 ing was 70.3% for all nodules, 95.6% for FDG-avid nodules, and 88.6% for nodules 0.5 cm in diameter o

216 A total of 69 nodules, including 45 FDG-avid nodules, were detected with PET/CT.

217 rger, with low sensitivity for small non-FDG-avid nodules.

218 e detection of small, non-fluorodeoxyglucose-avid nodules.

219 t surface expression is limited by the least avid of the two glutamate binding sites.

220 tastatic osteosarcoma or skeletal metastases avid on bone scan were treated with 1, 3, 4.5, 6, 12, 19

221 For each avid osseous lesion, we measured biologic volume; size;

222 Of the 25 [(18)F]FDG-avid osteoblastic lesions, 13 (52%) became [(18)F]FDG ne

223 erroportin expression, illustrated by a more avid oxidation of extracellular low-density lipoprotein

224 nd its putative radiometabolite 11C-dLop are avid P-gp substrates.

225 PET studies in normal rats demonstrated an avid pancreas uptake of (18)F-FP-(+)-DTBZ.

226 The galectin-3-avid peptide G3-C12 (ANTPCGPYTHDCPVKR) was synthesized w

227 rgeting and SPECT properties of a galectin-3-avid peptide identified from bacteriophage display were

228 e dyes to somatostatin and bombesin receptor-avid peptides and examined their receptor binding affini

229 an array of inflammatory stimuli but retain avid phagocytic and bacteriocidal activity.

230 for measuring the brightness using antibody-avid polystyrene beads and flow cytometry.

231 One hundred nineteen patients with (18)F-FDG-avid primary malignancies underwent a single-injection,

232 dy PET/CT detected new, unexpected (18)F-FDG-avid primary malignant tumors in at least 1.2% of patien

233 rred for a PET/CT-guided biopsy of (18)F-FDG-avid primary or metastatic lesions in different location

234 or the alignment comparisons, as well as the AVID program, are publicly available.

235 cortical thinning and multiple bilateral PET-avid pulmonary nodules, with the largest in the left upp

236 The use of tracer-avid radiopharmaceuticals and handheld, intraoperative,

237 Avid Radiopharmaceuticals, Banner Alzheimer's Foundation

238 Wolfson Foundation, Weston Brain Institute, Avid Radiopharmaceuticals.

239 /CT) with a glucagon-like peptide-1 receptor avid radiotracer, and compare detection rates with conve

240 4) retained picomolar functional potency and avid receptor binding properties.

241 e a regulatory program of slow induction and avid repression, and a fitness detriment during the gluc

242 rotein composition is currently a subject of avid research aimed at determining both fundamental prop

243 t difference in the PFS of patients with PET-avid residual disease in one site versus multiple sites

244 es recruited to the intestinal mucosa retain avid scavenger and host defense functions but acquire pr

245 but different, i.e., slower, for the Oncyte-Avid slide.

246 uted biomolecules was observed on the Oncyte-Avid slide.

247 m albumin (BSA) on FAST, Unisart, and Oncyte-Avid slides and compared the spot morphology of the inkj

248 ew, suggesting that dominant individuals are avid social learners, whereas subordinates focus on lear

249 Sodium appetite is an instinct that involves avid specific intention.

250 mIBG scans from 280 patients with mIBG-avid, stage 4 neuroblastoma enrolled on the Children's O

251 The derivatized peptide is an avid substrate and is suitable for use with biological s

252 ese enzymes, in some systems Ca(II) promotes avid substrate binding and sequence discrimination.

253 11C-Loperamide is an avid substrate for P-glycoprotein (P-gp), but it is rapi

254 PET with avid substrates of P-glycoprotein (ABCB1) provided evide

255 bstantial blockade to increase the uptake of avid substrates, blunting the ability of investigators t

256 study but indeed identified additional PSMA-avid suspected lesions in oligometastasized patients wit

257 ffinity sink during selections, and a highly avid target for subsequent immunoassay capture.

258 and three intraoperative biopsies of 36 FDG-avid targets between November 2007 and August 2010.

259 pose that inducing expression of this highly avid TCR in patient PBMC has the potential to induce tum

260 actin cytoskeleton, suggesting selection for avid TCR microclusters.

261 ontrary to pathogenic T cells, Tregs require avid TCR-ligand interaction to undergo thymic developmen

262 utated DTCs are significantly more (18)F-FDG-avid than BRAF-WT tumors.

263 d binding in the sensor gel is slightly less avid than in solution.

264 directed against variant epitopes were less avid than responses to vaccine-matched epitopes, we did

265 llow-up, with an improvement in LVEF and FDG-avid thoracic disease.

266 a specific method to detect non-radioiodine-avid thyroid cancer in thyroid orthotopic tumor models.

267 n simulating the presence of non-radioiodine-avid thyroid cancer nodules, and high accumulation in no

268 ed uptake value (SUV) was calculated for FDG-avid thyroid foci.

269 (18)F-FDG-avid thyroid incidentaloma (TI) is seen in approximately

270 considered before investigation of (18)F-FDG-avid TI and certainly before aggressive treatment.

271 Overall survival with (18)F-FDG-avid TI was poor because of the prognosis associated wit

272 nician decision not to investigate (18)F-FDG-avid TI were all predictors of mortality, with hazard ra

273 in a large cohort of patients with (18)F-FDG-avid TI with long-term follow-up to assess the validity

274 ultiple gp120s simultaneously, and is highly avid toward gp120, we could remove its capacity to enhan

275 ed by radionuclide imaging of the neutrophil-avid tracer 99mTcRP517 and tissue myeloperoxidase activi

276 hiosemicarbazone) (copper-ATSM) is a hypoxia-avid tracer for the selective identification of hypoxic

277 responses to furosemide (possibly reflecting avid tubular oxygen consumption) are associated with les

278 pting RT-escalated radiation dose to the FDG-avid tumor detected by midtreatment PET provided a favor

279 (68)Ga-DOTATOC-avid tumor lesions were semi-automatically delineated us

280 (68)Ga-DOTATOC-avid tumor lesions were semiautomatically delineated usi

281 RT can target high-dose radiation to the FDG-avid tumor on midtreatment FDG-PET to improve local tumo

282 /CT image analysis and total (68)Ga-DOTATATE-Avid tumor volume ((68)Ga-DOTATATE TV) was determined.

283 , 0.45; P = 0.024), whereas a (68)Ga-DOTATOC-avid tumor volume higher than 578 cm(3) (75th percentile

284 ) 0.45; P = 0.024), whereas a (68)Ga-DOTATOC-avid tumor volume higher than 578 ml (P75) was associate

285 Nine posttherapy WBS showed iodine-avid tumor, of which 4 also had positive (124)I PET/CT f

286 (61%) showing less than 25% (11)C-methionine-avid tumor.

287 e, 59 years; range, 35-87 years) with 29 FDG-avid tumors (median size, 1.4 cm; range, 0.6-4.4 cm) wer

288 Small, non-avid tumors and those within the hypermetabolic, PET-avi

289 pathologic parameters that allowed (18)F-FDG-avid tumors to be detected with a sensitivity of 85% and

290 All (18)F-FDG-avid tumors were delineated with an 50% threshold of SUV

291 used primarily in the setting of non-iodine-avid tumors.

292 and should not be confused with (99m)Tc-MIBI-avid-tumors.

293 n homeostasis in animals is a consequence of avid uptake and retention, except during conditions of l

294 An avid uptake of (18)F-TFB was observed in human NIS (hNIS

295 Sensitive AMLs showed more avid uptake of arginine from the extracellular environme

296 by neutrophils was observed, in contrast to avid uptake of IgA complexes.

297 small intestinal villi with the capacity for avid uptake of Salmonella and Yersinia organisms and flu

298 density lipoprotein (LDL) can result in the avid uptake of these lipoproteins via a family of macrop

299 See Web Site References section for AVID Web address and Web addresses for other programs di

300 also performed a quantitative comparison of AVID with other popular alignment tools.